BARABE TIMOTHY C — SEC Form 4 filings
SEC reporting owner CIK 1237409. 10 Form 4 filings on record with FilingPulse; latest filed 2026-07-24.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-08-14 to 2026-07-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 37,500 shares, $301,047 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: purchase of 30,000 shares @ $6.86 ($205,797) in Cartesian Therapeutics, Inc., filed 2025-12-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | Director | 4 | 2 legs · 37,500 sh · $301,047 | — | 4 |
| Heartflow, Inc. (HTFL) | Director | 6 | — | — | 12 |
Form 4 filings — BARABE TIMOTHY C
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-24 | 4 | Heartflow, Inc. (HTFL) | Option exercise (M): 3,710 @ $19 · Option exercise (M): 3,710 (derivative) @ $0 | EDGAR |
| 2026-07-20 | 4 | Heartflow, Inc. (HTFL) | Option exercise (M): 5,000 @ $19 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | Heartflow, Inc. (HTFL) | Grant/award (A): 16,075 (derivative) @ $32.05 | EDGAR |
| 2026-03-12 | 4 | Heartflow, Inc. (HTFL) | Option exercise (M): 8,667 @ $2.22 · Option exercise (M): 8,667 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | Heartflow, Inc. (HTFL) | Option exercise (M): 2,497 @ $8.33 · Option exercise (M): 2,497 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Cartesian Therapeutics, Inc. (RNAC) | Grant/award (A): 2,600 @ $0 · Grant/award (A): 7,800 (derivative) @ $0 | EDGAR |
| 2025-12-08 | 4 | Cartesian Therapeutics, Inc. (RNAC) | Purchase (P): 30,000 @ $6.86 | EDGAR |
| 2025-08-11 | 4 | Heartflow, Inc. (HTFL) | Conversion (C): 131,578 · Grant/award (A): 23,710 (derivative) @ $0 · Conversion (C): 131,578 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | Cartesian Therapeutics, Inc. (RNAC) | Grant/award (A): 2,600 @ $0 · Grant/award (A): 7,800 (derivative) @ $0 | EDGAR |
| 2024-08-14 | 4 | Cartesian Therapeutics, Inc. (RNAC) | Purchase (P): 7,500 @ $12.70 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1237409 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →